logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
H

Helen Mackay

Odette Cancer Centre

55H-index
403Paper Count
1.3WCitation Count
Published Papers 69
Publication Date
logo
Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2− and Triple-Negative Breast Cancer in Canada: The HER2− TRENDS Study
errAdvances in Therapy
IF4
err2026-03-10
err0
PREAI
errKaren Gambaro; Kahina Rachedi; Mark Basik; Gerald Batist; Fred Saad; Saima Hassan; Anne-Marie Mes-Masson; Dominique Boudreau; Francois Vincent; Eve St-Hilaire; Helen Mackay; Mahmoud Abdelsalam; Steven M. Yip; Robert Hanel; Simran Shokar; Zhor Senhaji Mouhri; Matthew Badin; Kristoph Klein-Panneton; Arif Ali Awan; Maud Marques
errShare
errSave
Evaluating the clinical utility and impact on healthcare utilization of serial troponin T monitoring in gynecologic cancer patients receiving immune checkpoint inhibitors – A single centre experience
errGynecologic Oncology
IF3.7
err2025-12-10
err0
errOAAI
errItalo Fernandes; Anjali Sachdeva; Farideh Tavangar; Matthew Lafreniere; Paul Yip; Teresa Petrella; Paaladinesh Thavendiranathan; Helen MacKay
errShare
errSave
Surgery versus definitive radiotherapy in the management of stage I-II small cell neuroendocrine carcinoma of the cervix: A systematic review and meta-analysis
errGynecologic Oncology
IF3.7
err2025-11-26
err0
errOAAI
errKevin Yijun Fan; Rania Chehade; Andrew Yuanbo Wang; Anjali Sachdeva; Farideh Tavangar; Helen J. MacKay; Amandeep S. Taggar
errShare
errSave
Randomized study evaluating optimal dose, efficacy, and safety of E7386 plus lenvatinib versus treatment of physician’s choice in advanced/recurrent endometrial carcinoma previously treated with platinum-based chemotherapy and immune checkpoint inhibitors
errInternational Journal of Gynecological Cancer
IF4.7
err2025-04-05
err0
PREAI
errRamez N. Eskander; Jung-Yun Lee; Mansoor Raza Mirza; Domenica Lorusso; Helen MacKay; Isabelle Ray-Coquard; Ana Oaknin; Antonio Gonzalez-Martin; Kosei Hasegawa; Bradley R. Corr; Xiaohua Wu; Alexandra Leary; Tianle Hu; Lea Dutta; Chinyere E. Okpara; Jodi McKenzie; Vicky Makker
errShare
errSave
Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial*
errgynecologic oncology
IF4.1
err2025-04-01
err0
PREAI
errLeath III, Charles A.; Deng, Wei; Mell, Loren K.; Richardson, Debra L.; Walker, Joan L.; Holman, Laura L.; Lea, Jayanthi S.; Amarnath, Sudha R.; Santos-Reyes, Luis Javier; Arend, Rebecca C.; Mayadev, Jyoti; Jegadeesh, Naresh; Disilvestro, Paul; Chon, Hye Sook; Ghamande, Sharad A.; Gao, Lei; Albuquerque, Kevin; Chino, Junzo P.; Donnelly, Eric; Feddock, Jonathan M.; Lowenstein, Jessica; Quick, Allison M.; Kunos, Charles M.; Macka, Helen; Aghajanian, Carol; Monk, Bradley J.
errShare
errSave
Characterization of tumor response with lenvatinib plus pembrolizumab (LEN plus Pembro) in the ENGOT-en9/LEAP-001 study
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errDanska-Bidzinska, A.; Makker, V.; Salutari, V.; Ayhan, A.; Romero, I.; Levy, T.; McCormack, M.; Baurain, J-F.; Mach, P.; Cadoo, K. A.; Mackay, H.; Friedlander, M. L.; Santin, A. D.; Slomovitz, B. M.; Miller, D. S.; McKenzie, J.; Yao, L.; Khemka, V.; Nogueira-Rodrigues, A.; Marth, C.
errShare
errSave
Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer
errOBSTETRICAL & GYNECOLOGICAL SURVEY
IF3.6
err2024-08-01
err0
PREAI
errHan, Kathy; Zou, Jinfeng; Zhao, Zhen; Baskurt, Zeynep; Zheng, Yangqiao; Barnes, Elizabeth; Croke, Jennifer; Ferguson, Sarah E.; Fyles, Anthony; Gien, Lilian; Gladwish, Adam; Lecavalier-Barsoum, Magali; Lheureux, Stephanie; Lukovic, Jelena; Mackay, Helen; Marchand, Eve-Lyne; Metser, Ur; Milosevic, Michael; Taggar, Amandeep S.; Bratman, Scott V.; Leung, Eric
errShare
errSave
Cell-free DNA in recurrent and metastatic endometrial cancer: The future is now? Promises and potential pitfalls
errCANCER
IF5.1
err2024-07-10
err0
PREAI
errMacKay, Helen; Fernandes, Italo
errShare
errSave
PARP inhibitors in non-ovarian gynecologic cancers
errTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
err2024-06-12
err2
errOAAI
errFernandes, Italo; Chehade, Rania; Mackay, Helen
errShare
errSave
Prediction of recurrence risk in endometrial cancer with multimodal deep learning
errNATURE MEDICINE
IF50
err2024-05-24
err4
errOAAI
errVolinsky-Fremond, Sarah; Horeweg, Nanda; Andani, Sonali; Wolf, Jurriaan Barkey; Lafarge, Maxime W.; de Kroon, Cor D.; Ortoft, Gitte; Hogdall, Estrid; Dijkstra, Jouke; Jobsen, Jan J.; Lutgens, Ludy C. H. W.; Powell, Melanie E.; Mileshkin, Linda R.; Mackay, Helen; Leary, Alexandra; Katsaros, Dionyssios; Nijman, Hans W.; de Boer, Stephanie M.; Nout, Remi A.; de Bruyn, Marco; Church, David; Smit, Vincent T. H. B. M.; Creutzberg, Carien L.; Koelzer, Viktor H.; Bosse, Tjalling
errShare
errSave
Live cell painting of drug responses in high grade serous cancer organoids
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errAndrews, David W.; Li, Betty; Schormann, Wiebke; Buzina, Alla; Gien, Lilian; MacKay, Helen
errShare
errSave
Novel germline genetic variants in pseudogenes associated with overall survival in advanced stage ovarian cancer treated with carboplatin, paclitaxel, and bevacizumab: Results from the ROSiA trial
errCANCER RESEARCH
IF16.6
err2024-03-04
err0
PREAI
errAlamleh, Salahaldin; Grant, Robert; Xu, Wei; Espin-Garcia, Osvaldo; MacKay, Helen; Liu, Geoffrey
errShare
errSave
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer
errCANCER
IF5.1
err2023-12-21
err4
PREAI
errRimel, Bobbie J.; Enserro, Danielle; Bender, David P.; Jackson, Camille Gunderson; Tan, Annie; Alluri, Nitya; Borowsky, Mark; Moroney, John; Hendrickson, Andrea Wahner; Backes, Floor; Swisher, Elizabeth; Powell, Matthew; MacKay, Helen
errShare
errSave
Molecular profiling of p53 mutant endometrial cancer reveals distinct subgroups with opportunities for personalized therapeutic approaches
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err0
errOAAI
errBlanc-Durand, F.; Kramer, C.; Rouleau, E.; Vasseur, D.; Bosse, T.; de Boer, S.; Edmondson, R.; Powell, M.; Crosbie, E.; Singh, N.; McAlpine, J.; Mackay, H.; Pollock, P.; Mileshkin, L.; Scott, C. L.; Ngoi, N. Y. L.; Lim, Y. W.; Lim, S. E.; Tan, D. S.; Leary, A.
errShare
errSave
Outcomes for patients (pts) with advanced endometrial cancer (aEC) who completed pembrolizumab (pembro) and continued lenvatinib (LEN) in the phase III Study 309/ KEYNOTE-775
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err0
errOAAI
errColomba, E.; Lorusso, D.; Mackay, H.; Moore, R.; Yonemori, K.; Kim, Y. M.; Sanli, U. A.; Xie, R.; Barresi, G.; McKenzie, J.; Makker, V.
errShare
errSave
Organoid models for predicting drug response in high grade serous and triple negative breast cancer
errCANCER RESEARCH
IF16.6
err2023-04-04
err0
PREAI
errMacKay, Helen J.; Buzina, Alla; Li, Betty; Gien, Lilian; Andrews, David
errShare
errSave
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma
errNATURE COMMUNICATIONS
IF15.7
err2023-03-15
err9
errOAAI
errMadariaga, Ainhoa; Garg, Swati; Tchrakian, Nairi; Dhani, Neesha C.; Jimenez, Waldo; Welch, Stephen; MacKay, Helen; Ethier, Josee-Lyne; Gilbert, Lucy; Li, Xuan; Rodriguez, Angela; Chan, Lucy; Bowering, Valerie; Clarke, Blaise; Zhang, Tong; King, Ian; Downs, Gregory; Stockley, Tracy; Wang, Lisa; Udagani, Smitha; Oza, Amit M.; Lheureux, Stephanie
errShare
errSave
Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts
errLANCET DIGITAL HEALTH
IF24.1
err2023-02-01
err33
errOAAI
errFremond, Sarah; Andani, Sonali; Wolf, Jurriaan Barkey; Dijkstra, Jouke; Melsbach, Sinead; Jobsen, Jan J.; Brinkhuis, Mariel; Roothaan, Suzan; Jurgenliemk-Schulz, Ina; Lutgens, Ludy C. H. W.; Nout, Remi A.; van der Steen-Banasik, Elzbieta M.; de Boer, Stephanie M.; Powell, Melanie E.; Singh, Naveena; Mileshkin, Linda R.; Mackay, Helen J.; Leary, Alexandra; Nijman, Hans W.; Smit, Vincent T. H. B. M.; Creutzberg, Carien L.; Horeweg, Nanda; Koelzer, Viktor H.; Bosse, Tjalling
errShare
errSave
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
errBRITISH JOURNAL OF CANCER
IF6.8
err2023-01-23
err73
errOAAI
errVermij, Lisa J.; Jobsen, Jan J.; Leon-Castillo, Alicia; Brinkhuis, Mariel; Roothaan, Suzan E.; Powell, Melanie E. M.; de Boer, Stephanie M.; Khaw, Pearly R.; Mileshkin, Linda R.; Fyles, Anthony; Leary, Alexandra; Genestie, Catherine M.; Jurgenliemk-Schulz, Ina M. J.; Crosbie, Emma J. J.; Mackay, Helen J.; Nijman, Hans. W. A.; Nout, Remi A.; Smit, Vincent T. H. B. M. L.; Creutzberg, Carien L.; Horeweg, Nanda; Bosse, Tjalling M.; de Boer, Stephanie M.
errShare
errSave
Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
errNATURE COMMUNICATIONS
IF15.7
err2022-03-16
err73
errOAAI
errHoreweg, Nanda; Workel, Hagma H.; Loiero, Dominik; Church, David N.; Vermij, Lisa; Leon-Castillo, Alicia; Krog, Ricki T.; de Boer, Stephanie M.; Nout, Remi A.; Powell, Melanie E.; Mileshkin, Linda R.; MacKay, Helen; Leary, Alexandra; Singh, Naveena; Juergenliemk-Schulz, Ina M.; Smit, Vincent T. H. B. M.; Creutzberg, Carien L.; Koelzer, Viktor H.; Nijman, Hans W.; Bosse, Tjalling; de Bruyn, Marco
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
E
Eric Van Cutsem
H-index: 174 · Papers: 1.8K
J
Jaffer A. Ajani
H-index: 152 · Papers: 1.7K
M
Ming‐Sound Tsao
H-index: 151 · Papers: 1.6K
D
David G. Huntsman
H-index: 147 · Papers: 1.1K
I
Ignace Vergote
H-index: 135 · Papers: 1.9K
View more